Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
The Procter & Gamble Company is a household & personal products business based in the US. The Procter-and-Gamble Company shares (PG) are listed on the NYSE and all prices are listed in US Dollars. The Procter-and-Gamble Company employs 99,000 staff and has a trailing 12-month revenue of around USD$72.5 billion.
Since the stock market crash in March caused by coronavirus, The Procter-and-Gamble Company's share price has had significant positive movement.
Its last market close was USD$144.39, which is 12.25% up on its pre-crash value of USD$126.7 and 53.05% up on the lowest point reached during the March crash when the shares fell as low as USD$94.34.
If you had bought USD$1,000 worth of The Procter-and-Gamble Company shares at the start of February 2020, those shares would have been worth USD$780.62 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,153.68.
|Latest market close||USD$144.39|
|52-week range||USD$92.6138 - USD$146.92|
|50-day moving average||USD$141.2864|
|200-day moving average||USD$130.0877|
|Wall St. target price||USD$150.31|
|Dividend yield||USD$3.16 (2.27%)|
|Earnings per share (TTM)||USD$5.233|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-17)||1.77%|
|1 month (2020-10-23)||1.41%|
|3 months (2020-08-24)||4.25%|
|6 months (2020-05-22)||28.23%|
|1 year (2019-11-22)||20.03%|
|2 years (2018-11-23)||57.73%|
|3 years (2017-11-24)||63.24%|
|5 years (2015-11-24)||88.87%|
Valuing The Procter-and-Gamble Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Procter-and-Gamble Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Procter-and-Gamble Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, The Procter-and-Gamble Company shares trade at around 27x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
The Procter-and-Gamble Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.6288. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Procter-and-Gamble Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The Procter-and-Gamble Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$20 billion.
The EBITDA is a measure of a The Procter-and-Gamble Company's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$72.5 billion|
|Operating margin TTM||23.57%|
|Gross profit TTM||USD$36.3 billion|
|Return on assets TTM||9.13%|
|Return on equity TTM||28.87%|
|Market capitalisation||USD$346.2 billion|
TTM: trailing 12 months
There are currently 13.9 million The Procter-and-Gamble Company shares held short by investors – that's known as The Procter-and-Gamble Company's "short interest". This figure is 7.2% up from 13.0 million last month.
There are a few different ways that this level of interest in shorting The Procter-and-Gamble Company shares can be evaluated.
The Procter-and-Gamble Company's "short interest ratio" (SIR) is the quantity of The Procter-and-Gamble Company shares currently shorted divided by the average quantity of The Procter-and-Gamble Company shares traded daily (recently around 5.9 million). The Procter-and-Gamble Company's SIR currently stands at 2.36. In other words for every 100,000 The Procter-and-Gamble Company shares traded daily on the market, roughly 2360 shares are currently held short.
However The Procter-and-Gamble Company's short interest can also be evaluated against the total number of The Procter-and-Gamble Company shares, or, against the total number of tradable The Procter-and-Gamble Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Procter-and-Gamble Company's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 The Procter-and-Gamble Company shares in existence, roughly 10 shares are currently held short) or 0.0056% of the tradable shares (for every 100,000 tradable The Procter-and-Gamble Company shares, roughly 6 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against The Procter-and-Gamble Company.
Find out more about how you can short The Procter-and-Gamble Company stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like The Procter-and-Gamble Company.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 25.68
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and The Procter-and-Gamble Company's overall score of 25.68 (as at 01/01/2019) is pretty good – landing it in it in the 40th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like The Procter-and-Gamble Company is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 12.71/100
The Procter-and-Gamble Company's environmental score of 12.71 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that The Procter-and-Gamble Company is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 10.97/100
The Procter-and-Gamble Company's social score of 10.97 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that The Procter-and-Gamble Company is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 11.51/100
The Procter-and-Gamble Company's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that The Procter-and-Gamble Company is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. The Procter-and-Gamble Company scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that The Procter-and-Gamble Company hasn't always managed to keep its nose clean.
|Total ESG score||25.68|
|Total ESG percentile||39.95|
|Environmental score percentile||5|
|Social score percentile||5|
|Governance score percentile||5|
|Level of controversy||3|
Dividend payout ratio: 57.96% of net profits
Recently The Procter-and-Gamble Company has paid out, on average, around 57.96% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.27% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Procter-and-Gamble Company shareholders could enjoy a 2.27% return on their shares, in the form of dividend payments. In The Procter-and-Gamble Company's case, that would currently equate to about $3.16 per share.
The Procter-and-Gamble Company's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The Procter-and-Gamble Company's most recent dividend payout was on 16 November 2020. The latest dividend was paid out to all shareholders who bought their shares by 22 October 2020 (the "ex-dividend date").
The Procter-and-Gamble Company's shares were split on a 2:1 basis on 21 June 2004. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your The Procter-and-Gamble Company shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for The Procter-and-Gamble Company shares which in turn could have impacted The Procter-and-Gamble Company's share price.
Over the last 12 months, The Procter-and-Gamble Company's shares have ranged in value from as little as $92.6138 up to $146.92. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while The Procter-and-Gamble Company's is 0.3968. This would suggest that The Procter-and-Gamble Company's shares are less volatile than average (for this exchange).
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. It operates in five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments; and antiperspirants and deodorants, personal cleansing, and skin care products under the Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, SK-II, and Secret brands. The Grooming segment provides female and male blades and razors, pre- and post-shave products, and other shave care products; and appliances that include electric shavers and epilators under the Braun, Gillette, and Venus brands. The Health Care segment offers toothbrushes, toothpaste, and other oral care products; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Crest, Oral-B, Metamucil, Neurobion, Pepto Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents; and air care, dish care, P&G professional, and surface care products under the Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment baby wipes, taped diapers, and pants; adult incontinence and feminine care products; and paper towels, tissues, and toilet papers under the Luvs, Pampers Always, Always Discreet, Tampax Bounty, Charmin, and Puffs brands. The company sells its products through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, baby stores, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
Everything we know about the NewRez IPO, plus information on how to buy in.
Everything we know about the Perella Weinberg IPO, plus information on how to buy in.
Everything we know about the Nanobiotix IPO, plus information on how to buy in.
Everything we know about the Diversey IPO, plus information on how to buy in.
Everything we know about the Certara IPO, plus information on how to buy in.
Everything we know about the Arrival IPO, plus information on how to buy in.
Everything we know about the iSpecimen IPO, plus information on how to buy in.
Everything we know about the IDEX Biometrics ASA IPO, plus information on how to buy in.
Steps to owning and managing MYSZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing MG, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.